Sancilio & Company will invest $6.7 million to expand its production facility in Riviera Beach, Florida. The company plans to create 275 jobs.

Founded in 2005, Sancilio & Company is engaged in the development, commercialization and manufacturing of branded prescription, over-the-counter and generic prescription pharmaceutical products. In 2007, the company began extensive research work on fish oil components, and discovered methods to analyze and isolate these materials. The company has developed and internationally distributes highly purified versions of these potent materials.

“It is a privilege and an honor to have the support of Governor Scott here at Sancilio & Company,” said Dr. Frederick Sancilio, Founder/CEO. “He and his administration continue the legacy of former Governor Jeb Bush’s commitment to the life sciences industry and the biopharma industry, the seeds of which were planted with the funding of Scripps and other bold initiatives. We are proud to be among several biopharma companies that have chosen to grow here in the area, which is directly attributable to the local partnerships and support from Palm Beach County and the City of Riviera Beach.”

Bill Johnson, Enterprise Florida President/CEO said, “Florida has become a well-known destination for both manufacturing and life sciences companies. Under Governor Scott’s leadership our state has become better for businesses and the pro-business climate here will allow companies like Sancilio & Company to continue to grow and succeed.”

This project was made possible by the close partnerships between Enterprise Florida, the Florida Department of Economic Opportunity, the City of Riviera Beach, Palm Beach County and the Business Development Board of Palm Beach County.